Neogenomics (NEO) Other financing activities (2012 - 2019)

Neogenomics has reported Other financing activities for 5 years, with the latest figure at $8000.0 in Q4 2019.

• For the quarter ending Q4 2019, Other financing activities changed N/A year-over-year to $8000.0; the trailing twelve-month figure through Dec 2020 stood at $105000.0 (changed 0.0% YoY), and the FY2019 full-year result was $1.1 million, up 83.85% from the prior year.
• Other financing activities for Q4 2019 stood at $8000.0, down from $97000.0 in the prior quarter.
• The five-year high for Other financing activities was $576000.0 in Q2 2018, with the low at -$112000.0 in Q3 2017.
• Historically, Other financing activities has averaged $129666.7 across 4 years, with a median of $97000.0 in 2016.
• The largest YoY upside for Other financing activities was 15.46% in 2017 against a maximum downside of 15.46% in 2017.
• Neogenomics' Other financing activities stood at $97000.0 in 2016, then plunged by 215.46% to -$112000.0 in 2017, then jumped by 614.29% to $576000.0 in 2018, then sank by 98.61% to $8000.0 in 2019.
• The last three Other financing activities figures came in at $8000.0 (Q4 2019), $97000.0 (Q3 2019), and $576000.0 (Q2 2018), per Business Quant data.